Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Champions Oncology (CSBR) Assets Average (2016 - 2026)

Champions Oncology (CSBR) has 14 years of Assets Average data on record, last reported at $30.4 million in Q4 2025.

  • For Q4 2025, Assets Average rose 21.0% year-over-year to $30.4 million; the TTM value through Oct 2025 reached $30.4 million, up 21.0%, while the annual FY2025 figure was $29.2 million, 3.25% down from the prior year.
  • Assets Average reached $30.4 million in Q4 2025 per CSBR's latest filing, down from $31.4 million in the prior quarter.
  • Across five years, Assets Average topped out at $36.3 million in Q1 2023 and bottomed at $25.1 million in Q4 2024.
  • Average Assets Average over 5 years is $30.2 million, with a median of $29.7 million recorded in 2023.
  • Peak YoY movement for Assets Average: surged 47.52% in 2021, then decreased 24.9% in 2024.
  • A 5-year view of Assets Average shows it stood at $28.7 million in 2021, then rose by 23.26% to $35.4 million in 2022, then decreased by 17.74% to $29.1 million in 2023, then dropped by 13.79% to $25.1 million in 2024, then rose by 21.0% to $30.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Assets Average were $30.4 million in Q4 2025, $31.4 million in Q3 2025, and $31.5 million in Q2 2025.